Hanna E Bloomfield1,2,3, Nancy Greer4,5, Amy M Linsky6, Jennifer Bolduc4, Todd Naidl4, Orly Vardeny4,7,5, Roderick MacDonald4,5, Lauren McKenzie4,5, Timothy J Wilt4,7,5. 1. Minneapolis VA Health Care System, Minneapolis, USA. hanna.bloomfield@va.gov. 2. University of Minnesota School of Medicine, Minneapolis, USA. hanna.bloomfield@va.gov. 3. Minneapolis VA Medical Center (151), 1 Veterans Drive, Minneapolis, MN, 55417, USA. hanna.bloomfield@va.gov. 4. Minneapolis VA Health Care System, Minneapolis, USA. 5. Minneapolis VA Center for Care Delivery and Outcomes Research, Minneapolis, USA. 6. VA Boston Healthcare System and Boston University School of Medicine, Boston, USA. 7. University of Minnesota School of Medicine, Minneapolis, USA.
Abstract
BACKGROUND: Polypharmacy and use of inappropriate medications have been linked to increased risk of falls, hospitalizations, cognitive impairment, and death. The primary objective of this review was to evaluate the effectiveness, comparative effectiveness, and harms of deprescribing interventions among community-dwelling older adults. METHODS: We searched OVID MEDLINE Embase, CINAHL, and the Cochrane Library from 1990 through February 2019 for controlled clinical trials comparing any deprescribing intervention to usual care or another intervention. Primary outcomes were all-cause mortality, hospitalizations, health-related quality of life, and falls. The secondary outcome was use of potentially inappropriate medications (PIMs). Interventions were categorized as comprehensive medication review, educational initiatives, and computerized decision support. Data abstracted by one investigator were verified by another. We used the Cochrane criteria to rate risk of bias for each study and the GRADE system to determine certainty of evidence (COE) for primary outcomes. RESULTS: Thirty-eight low and medium risk of bias clinical trials were included. Comprehensive medication review may have reduced all-cause mortality (OR 0.74, 95% CI: 0.58 to 0.95, I2 = 0, k = 12, low COE) but probably had little to no effect on falls, health-related quality of life, or hospitalizations (low to moderate COE). Nine of thirteen trials reported fewer PIMs in the intervention group. Educational interventions probably had little to no effect on all-cause mortality, hospitalizations, or health-related quality of life (low to moderate COE). The effect on falls was uncertain (very low COE). All 11 education trials that included PIMs reported fewer in the intervention than in the control groups. Two of 4 computerized decision support trials reported fewer PIMs in the intervention arms; none included any primary outcomes. DISCUSSION: In community-dwelling people aged 65 years and older, medication deprescribing interventions may provide small reductions in mortality and use of potentially inappropriate medications. REGISTRY INFORMATION: PROSPERO - CRD42019132420.
BACKGROUND: Polypharmacy and use of inappropriate medications have been linked to increased risk of falls, hospitalizations, cognitive impairment, and death. The primary objective of this review was to evaluate the effectiveness, comparative effectiveness, and harms of deprescribing interventions among community-dwelling older adults. METHODS: We searched OVID MEDLINE Embase, CINAHL, and the Cochrane Library from 1990 through February 2019 for controlled clinical trials comparing any deprescribing intervention to usual care or another intervention. Primary outcomes were all-cause mortality, hospitalizations, health-related quality of life, and falls. The secondary outcome was use of potentially inappropriate medications (PIMs). Interventions were categorized as comprehensive medication review, educational initiatives, and computerized decision support. Data abstracted by one investigator were verified by another. We used the Cochrane criteria to rate risk of bias for each study and the GRADE system to determine certainty of evidence (COE) for primary outcomes. RESULTS: Thirty-eight low and medium risk of bias clinical trials were included. Comprehensive medication review may have reduced all-cause mortality (OR 0.74, 95% CI: 0.58 to 0.95, I2 = 0, k = 12, low COE) but probably had little to no effect on falls, health-related quality of life, or hospitalizations (low to moderate COE). Nine of thirteen trials reported fewer PIMs in the intervention group. Educational interventions probably had little to no effect on all-cause mortality, hospitalizations, or health-related quality of life (low to moderate COE). The effect on falls was uncertain (very low COE). All 11 education trials that included PIMs reported fewer in the intervention than in the control groups. Two of 4 computerized decision support trials reported fewer PIMs in the intervention arms; none included any primary outcomes. DISCUSSION: In community-dwelling people aged 65 years and older, medication deprescribing interventions may provide small reductions in mortality and use of potentially inappropriate medications. REGISTRY INFORMATION: PROSPERO - CRD42019132420.
Authors: Robyn Tamblyn; Allen Huang; Robert Perreault; André Jacques; Denis Roy; James Hanley; Peter McLeod; Réjean Laprise Journal: CMAJ Date: 2003-09-16 Impact factor: 8.262
Authors: Daniel R Touchette; Andrew L Masica; Rowena J Dolor; Glen T Schumock; Young Ku Choi; Yoonsang Kim; Scott R Smith Journal: J Am Pharm Assoc (2003) Date: 2012 Sep-Oct
Authors: Paddy Gillespie; Barbara Clyne; Adam Raymakers; Tom Fahey; Carmel M Hughes; Susan M Smith Journal: Int J Technol Assess Health Care Date: 2017-10-11 Impact factor: 2.188
Authors: Audrey Rankin; Cathal A Cadogan; Susan M Patterson; Ngaire Kerse; Chris R Cardwell; Marie C Bradley; Cristin Ryan; Carmel Hughes Journal: Cochrane Database Syst Rev Date: 2018-09-03
Authors: Barbara Clyne; Susan M Smith; Carmel M Hughes; Fiona Boland; Janine A Cooper; Tom Fahey Journal: Implement Sci Date: 2016-06-02 Impact factor: 7.327
Authors: Christiane Muth; Lorenz Uhlmann; Walter E Haefeli; Justine Rochon; Marjan van den Akker; Rafael Perera; Corina Güthlin; Martin Beyer; Frank Oswald; Jose Maria Valderas; J André Knottnerus; Ferdinand M Gerlach; Sebastian Harder Journal: BMJ Open Date: 2018-02-24 Impact factor: 2.692
Authors: Michael A Steinman; Cynthia M Boyd; Malena J Spar; Jonathan D Norton; Cara Tannenbaum Journal: J Am Geriatr Soc Date: 2021-09-09 Impact factor: 5.562
Authors: Parag Goyal; Monika M Safford; Sarah N Hilmer; Michael A Steinman; Daniel D Matlock; Mathew S Maurer; Mark S Lachs; Ian M Kronish Journal: Br J Clin Pharmacol Date: 2022-07-13 Impact factor: 3.716
Authors: Elizabeth A Bayliss; Kathleen Albers; Kathy Gleason; Lisa E Pieper; Cynthia M Boyd; Noll L Campbell; Kristine E Ensrud; Shelly L Gray; Amy M Linsky; Derelie Mangin; Lillian Min; Michael W Rich; Michael A Steinman; Justin Turner; Eduard E Vasilevskis; Sascha Dublin Journal: J Am Geriatr Soc Date: 2022-06-01 Impact factor: 7.538
Authors: Ephrem Abebe; Noll L Campbell; Daniel O Clark; Wanzhu Tu; Jordan R Hill; Addison B Harrington; Gracen O'Neal; Kimberly S Trowbridge; Christian Vallejo; Ziyi Yang; Na Bo; Alexxus Knight; Khalid A Alamer; Allie Carter; Robin Valenzuela; Philip Adeoye; Malaz A Boustani; Richard J Holden Journal: Res Social Adm Pharm Date: 2020-10-22